ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Articles
Latest Testosterone News and Conference Posters
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 272975" data-attributes="member: 3"><p>[h2][style=color: #1a0dab;][PDF][/style] <a href="http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42185-4/pdf&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm2dUpTcJ4YdUqQW4z0UotWZ55n-VA&amp;nossl=1&amp;oi=scholaralrt" target="_blank">MP85-13 ERECTILE FUNCTION IN 478 HYPOGONADAL [style=font-weight: bold;]MEN[/style]WITH MODERATE TO SEVERE ED WITH AND WITHOUT [style=font-weight: bold;]TESTOSTERONE[/style]THERAPY FOR UP TO …</a>[/h2]</p><p>[style=color: #006621;]A Haider, KS Haider, G Doros, A Traish - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS 478 men[/style]with [style=font-weight: bold;]testosterone[/style]? 350 ng/dL and hypogonadal symptoms had</p><p>moderate to severe ED according to IIEF-EF (5+ 1, maximum score: 30). 246</p><p>received [style=font-weight: bold;]testosterone[/style]undecanoate injections (TU) 1000 mg/12 weeks following an …</p><p></p><p> </p><p>[h2][style=color: #1a0dab;][PDF][/style] <a href="http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42187-8/pdf&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm36J2a6Z5PyBoI_8zsVGetsrng5ZQ&amp;nossl=1&amp;oi=scholaralrt" target="_blank">MP85-15 [style=font-weight: bold;]TESTOSTERONE[/style]TREATMENT IN [style=font-weight: bold;]MEN[/style]WITH CLASSICAL VS FUNCTIONAL HYPOGONADISM: RESULTS FROM A 9-YEAR-REGISTRY</a>[/h2]</p><p>[style=color: #006621;]M Zitzmann, E Nieschlag, A Traish, S Kliesch - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS Registry data of max. 9 years comprising 650 patients with</p><p>hypogonadism including 266 men[/style]with primary (mean age 34.0±11.7 years), 196</p><p>with secondary (mean age 31.9±12.0 years) and 188 with functional hypogonadism …</p><p></p><p> </p><p>[h2][style=color: #1a0dab;][PDF][/style] <a href="http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42153-2/pdf&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm3ONbwpzPyuiLf4YhAI-MdwltHrIA&amp;nossl=1&amp;oi=scholaralrt" target="_blank">PD62-05 BRIDGING THE GAP BETWEEN LOW [style=font-weight: bold;]TESTOSTERONE[/style]AND PROSTATE INFLAMMATION IN HYPOGONADAL [style=font-weight: bold;]MEN[/style]</a>[/h2]</p><p>[style=color: #006621;]A Gabrielson, A Reddy, A Sholl, L Alzweri… - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS Twenty prostate specimens from patients (10 hypogonadal, 10</p><p>eugonadal) were stained for p65 (NF-? B) and TGF-? receptor (TGF-?R) expression.</p><p>Patients were stratified by pre-RP testosterone[/style]:&lt; 300 ng/dL as hypogonadal,&gt; 400 …</p><p></p><p> </p><p>[h2][style=color: #1a0dab;][PDF][/style] <a href="http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42186-6/pdf&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm00C-7pP4oJg51KS1UuiitROb8LEA&amp;nossl=1&amp;oi=scholaralrt" target="_blank">MP85-14 VARIANCE IN PEAK AND TROUGH [style=font-weight: bold;]TESTOSTERONE[/style]LEVELS IN [style=font-weight: bold;]MEN[/style]USING INTRAMUSCULAR [style=font-weight: bold;]TESTOSTERONE[/style]</a>[/h2]</p><p>[style=color: #006621;]B Nascimento, HL Bernie, E Schofield, JP Mulhall - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS Patients with 3 consecutive Tp and Tt levels available, while on a stable</p><p>dose and interval of IM T cypionate were analyzed. All <strong><a href="https://www.excelmale.com/how-to-increase-testosterone-naturally-2/" target="_blank">patients</a> </strong>were instructed as</p><p>follows: Tp levels to checked 18 hours after IM T injection, and Tt levels to be drawn …[/style]</p><p></p><p> </p><p>[h2]<a href="http://scholar.google.com/scholar_url?url=https://www.sciencedirect.com/science/article/pii/S0022534718421787&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm3P2y-iJ5IEzub3ByawqueL4_ZUZw&amp;nossl=1&amp;oi=scholaralrt" target="_blank">MP85-06 TOREMIFENE CITRATE IMPROVES HIGH-DENSITY LIPOPROTEIN LEVELS IN [style=font-weight: bold;]MEN[/style]ON [style=font-weight: bold;]TESTOSTERONE[/style]REPLACEMENT THERAPY</a>[/h2]</p><p>[style=color: #006621;]DJ Mazur, TP Kohn, A Perez-Orozco, JA McBride… - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS Men[/style]on TTh with low HDL levels (&lt; 39 mg/dL) at a single andrology clinic</p><p>treated between October 2015 and August 2017 with either toremifine (60 mg daily),</p><p>niacin (titrated to 1,000 mg daily over 2 months) plus krill oil (1,000 mg daily)(NKO) …</p><p></p><p> </p><p>[h2]<a href="http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42020-4/abstract&amp;hl=en&amp;sa=X&amp;scisig=AAGBfm2Admg9zPtHZaUMF2lqeRRCIyTVVg&amp;nossl=1&amp;oi=scholaralrt" target="_blank">MP80-20 USE OF NON-[style=font-weight: bold;]TESTOSTERONE[/style]BASED HORMONE THERAPIES AMONG PRIVATELY INSURED US [style=font-weight: bold;]MEN[/style], 2009-2015</a>[/h2]</p><p>[style=color: #006621;]M Henry, D Patil, A Nangia, A Mehta - The Journal of Urology, 2018[/style]</p><p>[style=font-family: arial;]METHODS We used 2009-2015 Truven Health MarketScan Data to identify men[/style]</p><p>using T &amp; non-T hormone therapies (clomiphene citrate, aromatase inhibitors, human</p><p>chorionic gonadotropin (hCG), &amp; follicle stimulating hormone (FSH)), using National.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 272975, member: 3"] [h2][style=color: #1a0dab;][PDF][/style] [url=http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42185-4/pdf&hl=en&sa=X&scisig=AAGBfm2dUpTcJ4YdUqQW4z0UotWZ55n-VA&nossl=1&oi=scholaralrt]MP85-13 ERECTILE FUNCTION IN 478 HYPOGONADAL [style=font-weight: bold;]MEN[/style]WITH MODERATE TO SEVERE ED WITH AND WITHOUT [style=font-weight: bold;]TESTOSTERONE[/style]THERAPY FOR UP TO …[/url][/h2] [style=color: #006621;]A Haider, KS Haider, G Doros, A Traish - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS 478 men[/style]with [style=font-weight: bold;]testosterone[/style]? 350 ng/dL and hypogonadal symptoms had moderate to severe ED according to IIEF-EF (5+ 1, maximum score: 30). 246 received [style=font-weight: bold;]testosterone[/style]undecanoate injections (TU) 1000 mg/12 weeks following an … [h2][style=color: #1a0dab;][PDF][/style] [url=http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42187-8/pdf&hl=en&sa=X&scisig=AAGBfm36J2a6Z5PyBoI_8zsVGetsrng5ZQ&nossl=1&oi=scholaralrt]MP85-15 [style=font-weight: bold;]TESTOSTERONE[/style]TREATMENT IN [style=font-weight: bold;]MEN[/style]WITH CLASSICAL VS FUNCTIONAL HYPOGONADISM: RESULTS FROM A 9-YEAR-REGISTRY[/url][/h2] [style=color: #006621;]M Zitzmann, E Nieschlag, A Traish, S Kliesch - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS Registry data of max. 9 years comprising 650 patients with hypogonadism including 266 men[/style]with primary (mean age 34.0±11.7 years), 196 with secondary (mean age 31.9±12.0 years) and 188 with functional hypogonadism … [h2][style=color: #1a0dab;][PDF][/style] [url=http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42153-2/pdf&hl=en&sa=X&scisig=AAGBfm3ONbwpzPyuiLf4YhAI-MdwltHrIA&nossl=1&oi=scholaralrt]PD62-05 BRIDGING THE GAP BETWEEN LOW [style=font-weight: bold;]TESTOSTERONE[/style]AND PROSTATE INFLAMMATION IN HYPOGONADAL [style=font-weight: bold;]MEN[/style][/url][/h2] [style=color: #006621;]A Gabrielson, A Reddy, A Sholl, L Alzweri… - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS Twenty prostate specimens from patients (10 hypogonadal, 10 eugonadal) were stained for p65 (NF-? B) and TGF-? receptor (TGF-?R) expression. Patients were stratified by pre-RP testosterone[/style]:< 300 ng/dL as hypogonadal,> 400 … [h2][style=color: #1a0dab;][PDF][/style] [url=http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42186-6/pdf&hl=en&sa=X&scisig=AAGBfm00C-7pP4oJg51KS1UuiitROb8LEA&nossl=1&oi=scholaralrt]MP85-14 VARIANCE IN PEAK AND TROUGH [style=font-weight: bold;]TESTOSTERONE[/style]LEVELS IN [style=font-weight: bold;]MEN[/style]USING INTRAMUSCULAR [style=font-weight: bold;]TESTOSTERONE[/style][/url][/h2] [style=color: #006621;]B Nascimento, HL Bernie, E Schofield, JP Mulhall - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS Patients with 3 consecutive Tp and Tt levels available, while on a stable dose and interval of IM T cypionate were analyzed. All [b][url=https://www.excelmale.com/how-to-increase-testosterone-naturally-2/]patients[/url] [/b]were instructed as follows: Tp levels to checked 18 hours after IM T injection, and Tt levels to be drawn …[/style] [h2][url=http://scholar.google.com/scholar_url?url=https://www.sciencedirect.com/science/article/pii/S0022534718421787&hl=en&sa=X&scisig=AAGBfm3P2y-iJ5IEzub3ByawqueL4_ZUZw&nossl=1&oi=scholaralrt]MP85-06 TOREMIFENE CITRATE IMPROVES HIGH-DENSITY LIPOPROTEIN LEVELS IN [style=font-weight: bold;]MEN[/style]ON [style=font-weight: bold;]TESTOSTERONE[/style]REPLACEMENT THERAPY[/url][/h2] [style=color: #006621;]DJ Mazur, TP Kohn, A Perez-Orozco, JA McBride… - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS Men[/style]on TTh with low HDL levels (< 39 mg/dL) at a single andrology clinic treated between October 2015 and August 2017 with either toremifine (60 mg daily), niacin (titrated to 1,000 mg daily over 2 months) plus krill oil (1,000 mg daily)(NKO) … [h2][url=http://scholar.google.com/scholar_url?url=http://www.jurology.com/article/S0022-5347(18)42020-4/abstract&hl=en&sa=X&scisig=AAGBfm2Admg9zPtHZaUMF2lqeRRCIyTVVg&nossl=1&oi=scholaralrt]MP80-20 USE OF NON-[style=font-weight: bold;]TESTOSTERONE[/style]BASED HORMONE THERAPIES AMONG PRIVATELY INSURED US [style=font-weight: bold;]MEN[/style], 2009-2015[/url][/h2] [style=color: #006621;]M Henry, D Patil, A Nangia, A Mehta - The Journal of Urology, 2018[/style] [style=font-family: arial;]METHODS We used 2009-2015 Truven Health MarketScan Data to identify men[/style] using T & non-T hormone therapies (clomiphene citrate, aromatase inhibitors, human chorionic gonadotropin (hCG), & follicle stimulating hormone (FSH)), using National. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Articles
Latest Testosterone News and Conference Posters
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top